Dr Daniel Neill
Molecular Microbiology, School of Life Sciences
+44 (0)1382 388899
Daniel Neill is Principal Investigator within the Division of Molecular Microbiology. He obtained a PhD in infection immunology from the MRC Laboratory of Molecular Biology, Cambridge, in 2010. He worked as a post-doctoral researcher, first at the University of Leicester, and later, from 2012, at the University of Liverpool. Whilst at Liverpool, he was awarded a Wellcome and Royal Society Sir Henry Dale fellowship and a Tenure Track fellowship, enabling him to establish his own research group. He moved to the University of Dundee, as Senior Lecturer, in 2023.
Our lab is interested in bacterial infections of the airways. In particular, we are seek to understand how the physical, chemical and biological environment of the respiratory tract influences bacterial phenotypes, including those associated with virulence and antimicrobial resistance. Several of the species that we study can act as commensals or asymptomatic colonisers of the upper airways but are also capable of causing severe disease when they descend into the lower regions of the respiratory system. We aim to understand the relationship between commensalism and pathogenesis in these species and to define the host and pathogen factors that drive a switch between the two modes of life.
Much of the work of the lab is centred around Streptococcus pneumoniae, a leading cause of pneumonia, meningitis and sepsis, and Pseudomonas aeruginosa, the major pathogen of the cystic fibrosis lung and a common cause of hospital-acquired infection. Ongoing work examines the process of pathogen adaptation to host environments, using experimental evolution approaches. We also aim to improve on existing in vitro and in vivo models of infection, to better capture the key conditions of the respiratory tract in health and disease. A long-term goal is the development of novel therapeutics and vaccines for treatment and prevention of bacterial respiratory diseases.
An innate pathogen sensing strategy involving ubiquitination of bacterial surface proteins.
Apte S, Bhutda S, Ghosh S, Sharma K, Barton TE, Dibyachintan S, Sahay O, Roy S, Sinha AR, Adicherla H, Rakshit J, Tang S, Datey A, Santra S, Joseph J, Sasidharan S, Hammerschmidt S, Chakravortty D, Oggioni MR, Santra MK, Neill DR, Banerjee A. Sci Adv. 2023 Mar 22;9(12):eade1851. doi: 10.1126/sciadv.ade1851. Epub 2023 Mar 22. PMID: 36947610
Influence of Streptococcus pneumoniae Within-Strain Population Diversity on Virulence and Pathogenesis.
Jacques LC, Green AE, Barton TE, Baltazar M, Aleksandrowicz J, Xu R, Trochu E, Kadioglu A, Neill DR. Microbiol Spectr. 2023 Feb 14;11(1):e0310322. doi: 10.1128/spectrum.03103-22. Epub 2022 Dec 12. PMID: 36507681
TNFR2+ regulatory T cells protect against bacteremic pneumococcal pneumonia by suppressing IL-17A-producing γδ T cells in the lung.
Xu R, Jacques LC, Khandaker S, Beentjes D, Leon-Rios M, Wei X, French N, Neill DR, Kadioglu A. Cell Rep. 2023 Jan 30;42(2):112054. doi: 10.1016/j.celrep.2023.112054. PMID: 36724074
Pseudomonas aeruginosa utilizes the host-derived polyamine spermidine to facilitate antimicrobial tolerance.
Hasan CM, Pottenger S, Green AE, Cox AA, White JS, Jones T, Winstanley C, Kadioglu A, Wright MH, Neill DR, Fothergill JL. JCI Insight. 2022 Nov 22;7(22):e158879. doi: 10.1172/jci.insight.158879. PMID: 36194492
Development of liquid culture media mimicking the conditions of sinuses and lungs in cystic fibrosis and health.
Ruhluel D, O'Brien S, Fothergill JL, Neill DR. F1000Res. 2022 Sep 7;11:1007. doi: 10.12688/f1000research.125074.2. eCollection 2022. PMID: 36519007
Pneumococcal Colonization and Virulence Factors Identified Via Experimental Evolution in Infection Models.
Green AE, Howarth D, Chaguza C, Echlin H, Langendonk RF, Munro C, Barton TE, Hinton JCD, Bentley SD, Rosch JW, Neill DR. Mol Biol Evol. 2021 May 19;38(6):2209-2226. doi: 10.1093/molbev/msab018. PMID: 33502519
Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle.
Badgujar DC, Anil A, Green AE, Surve MV, Madhavan S, Beckett A, Prior IA, Godsora BK, Patil SB, More PK, Sarkar SG, Mitchell A, Banerjee R, Phale PS, Mitchell TJ, Neill DR, Bhaumik P, Banerjee A. PLoS Pathog. 2020 Nov 20;16(11):e1009016. doi: 10.1371/journal.ppat.1009016. eCollection 2020 Nov. PMID: 33216805
Influenza-like illness is associated with high pneumococcal carriage density in Malawian children.
Nyazika TK, Law A, Swarthout TD, Sibale L, Ter Braake D, French N, Heyderman RS, Everett D, Kadioglu A, Jambo KC, Neill DR. J Infect. 2020 Oct;81(4):549-556. doi: 10.1016/j.jinf.2020.06.079. Epub 2020 Jul 22. PMID: 32711042
Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin.
Jacques LC, Panagiotou S, Baltazar M, Senghore M, Khandaker S, Xu R, Bricio-Moreno L, Yang M, Dowson CG, Everett DB, Neill DR, Kadioglu A. Nat Commun. 2020 Apr 20;11(1):1892. doi: 10.1038/s41467-020-15751-6. PMID: 32312961
Exposure to diesel exhaust particles increases susceptibility to invasive pneumococcal disease.
Shears RK, Jacques LC, Naylor G, Miyashita L, Khandaker S, Lebre F, Lavelle EC, Grigg J, French N, Neill DR, Kadioglu A. J Allergy Clin Immunol. 2020 Apr;145(4):1272-1284.e6. doi: 10.1016/j.jaci.2019.11.039. Epub 2020 Jan 23. PMID: 31983527
Host-pathogen interactions and bacterial adaptations to the respiratory tract environment
|Wellcome and Royal Society Sir Henry Dale Fellowship||2023|